General Information of Drug (ID: DMWHLMD)

Drug Name
QS-21
Synonyms AC1L1U2U; C92H148O46; LS-173109; 124716-EP2295426A1
Indication
Disease Entry ICD 11 Status REF
Melanoma 2C30 Phase 3 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C92H148O46
Canonical SMILES
CCC(C)C(CC(CC(=O)OC(CC(CC(=O)OC1C(OC(C(C1O)OC2C(C(C(C(O2)C)OC3C(C(C(CO3)OC4C(C(CO4)(CO)O)O)O)O)O)O)OC(=O)C56CCC(CC5C7=CCC8C9(CCC(C(C9CCC8(C7(CC6O)C)C)(C)C=O)OC1C(C(C(C(O1)C(=O)O)O)OC1C(C(C(CO1)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)(C)C)C)O)C(C)CC)O)OC1C(C(C(O1)CO)O)O
InChI
1S/C92H148O46/c1-13-36(3)45(126-54(101)25-41(98)24-46(37(4)14-2)127-80-64(111)58(105)48(30-94)128-80)23-40(97)26-55(102)132-70-39(6)125-82(73(67(70)114)136-79-66(113)61(108)69(38(5)124-79)133-78-63(110)59(106)49(32-122-78)130-84-75(116)91(120,34-96)35-123-84)138-85(119)92-22-21-86(7,8)27-43(92)42-15-16-51-87(9)19-18-53(88(10,33-95)50(87)17-20-89(51,11)90(42,12)28-52(92)100)131-83-74(137-81-65(112)60(107)57(104)47(29-93)129-81)71(68(115)72(135-83)76(117)118)134-77-62(109)56(103)44(99)31-121-77/h15,33,36-41,43-53,56-75,77-84,93-94,96-100,103-116,120H,13-14,16-32,34-35H2,1-12H3,(H,117,118)/t36?,37?,38-,39+,40?,41?,43-,44+,45?,46?,47+,48-,49+,50+,51+,52+,53-,56-,57-,58-,59-,60-,61-,62+,63+,64+,65+,66+,67-,68-,69-,70-,71-,72-,73+,74+,75-,77-,78-,79-,80+,81+,82-,83+,84-,87-,88-,89+,90+,91+,92+/m0/s1
InChIKey
XYVMMKXMQBIPIQ-JOMHPNDBSA-N
Cross-matching ID
PubChem CID
60866
TTD ID
D03WOW

References

1 ClinicalTrials.gov (NCT00005052) Vaccine Therapy in Treating Patients With Primary Stage II Melanoma. U.S. National Institutes of Health.